Acellular pertussis vaccine at birth induces early immunogenicity

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1394, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

By Iskedjian M. Einarson T.R.

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 551-563

Adis International

Access to resources Recommend Favorite

New acellular pertussis vaccine superior in Ontario, Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Acellular pertussis vaccine protects adolescents, adults

Inpharma, Vol. 1, Iss. 1510, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Economic Evaluation of an Extended Acellular Pertussis Vaccine Program for Adolescents in Québec, Canada

By Iskedjian Michael

Pediatric Drugs, Vol. 7, Iss. 2, 2005-01 ,pp. : 123-136

Adis International

Access to resources Recommend Favorite

Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix )

By Chapman T.M. Goa K.L.

Drugs, Vol. 63, Iss. 13, 2003-01 ,pp. : 1407-1413

Adis International

Access to resources Recommend Favorite